BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28196902)

  • 1. Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure.
    Chowdhury B; Xiang B; Liu M; Hemming R; Dolinsky VW; Triggs-Raine B
    Circ Cardiovasc Genet; 2017 Jan; 10(1):e001598. PubMed ID: 28196902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction.
    Chowdhury B; Hemming R; Hombach-Klonisch S; Flamion B; Triggs-Raine B
    J Biol Chem; 2013 Jan; 288(1):520-8. PubMed ID: 23172227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronidase 2 (HYAL2) is expressed in endothelial cells, as well as some specialized epithelial cells, and is required for normal hyaluronan catabolism.
    Chowdhury B; Hemming R; Faiyaz S; Triggs-Raine B
    Histochem Cell Biol; 2016 Jan; 145(1):53-66. PubMed ID: 26515055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease.
    Prakash S; Borreguero LJJ; Sylva M; Flores Ruiz L; Rezai F; Gunst QD; de la Pompa JL; Ruijter JM; van den Hoff MJB
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e116-e130. PubMed ID: 28705792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.
    Bourguignon V; Flamion B
    FASEB J; 2016 Jun; 30(6):2108-14. PubMed ID: 26887442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
    Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?
    Jadin L; Wu X; Ding H; Frost GI; Onclinx C; Triggs-Raine B; Flamion B
    FASEB J; 2008 Dec; 22(12):4316-26. PubMed ID: 18772348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Malaisse J; Flamion B; Caron N
    Kidney Int; 2015 Jul; 88(1):61-71. PubMed ID: 25715119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in HYAL2, Encoding Hyaluronidase 2, Cause a Syndrome of Orofacial Clefting and Cor Triatriatum Sinister in Humans and Mice.
    Muggenthaler MM; Chowdhury B; Hasan SN; Cross HE; Mark B; Harlalka GV; Patton MA; Ishida M; Behr ER; Sharma S; Zahka K; Faqeih E; Blakley B; Jackson M; Lees M; Dolinsky V; Cross L; Stanier P; Salter C; Baple EL; Alkuraya FS; Crosby AH; Triggs-Raine B; Chioza BA
    PLoS Genet; 2017 Jan; 13(1):e1006470. PubMed ID: 28081210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet hyaluronidase-2 regulates the early stages of inflammatory disease in colitis.
    Petrey AC; Obery DR; Kessler SP; Zawerton A; Flamion B; de la Motte CA
    Blood; 2019 Aug; 134(9):765-775. PubMed ID: 31262781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.
    Gogiraju R; Xu X; Bochenek ML; Steinbrecher JH; Lehnart SE; Wenzel P; Kessel M; Zeisberg EM; Dobbelstein M; Schäfer K
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition.
    Murdoch CE; Chaubey S; Zeng L; Yu B; Ivetic A; Walker SJ; Vanhoutte D; Heymans S; Grieve DJ; Cave AC; Brewer AC; Zhang M; Shah AM
    J Am Coll Cardiol; 2014 Jun; 63(24):2734-41. PubMed ID: 24681145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditionally targeted deletion of PSEN1 leads to diastolic heart dysfunction.
    Song XW; Yuan QN; Tang Y; Cao M; Shen YF; Zeng ZY; Lei CH; Li S; Zhao XX; Yang YJ
    J Cell Physiol; 2018 Feb; 233(2):1548-1557. PubMed ID: 28617969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronidase 2: a novel germ cell hyaluronidase with epididymal expression and functional roles in mammalian sperm.
    Modelski MJ; Menlah G; Wang Y; Dash S; Wu K; Galileo DS; Martin-DeLeon PA
    Biol Reprod; 2014 Nov; 91(5):109. PubMed ID: 25232017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.
    Bertrand P; Courel MN; Maingonnat C; Jardin F; Tilly H; Bastard C
    Int J Cancer; 2005 Jan; 113(2):207-12. PubMed ID: 15386412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
    Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan degradation by HYAL2 is essential for odontoblastic differentiation and migration of mouse dental papilla cells.
    Huang H; Hu X; Wu J; Song C; Tian Z; Jiang B
    Matrix Biol; 2024 May; 129():1-14. PubMed ID: 38490466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation.
    Atmuri V; Martin DC; Hemming R; Gutsol A; Byers S; Sahebjam S; Thliveris JA; Mort JS; Carmona E; Anderson JE; Dakshinamurti S; Triggs-Raine B
    Matrix Biol; 2008 Oct; 27(8):653-60. PubMed ID: 18762256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
    Berry JM; Le V; Rotter D; Battiprolu PK; Grinsfelder B; Tannous P; Burchfield JS; Czubryt M; Backs J; Olson EN; Rothermel BA; Hill JA
    Circ Res; 2011 Aug; 109(4):407-17. PubMed ID: 21700928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.